Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis.
Tai Van NguyenDiaddin HamdanGéraldine FalgaroneKien Hung DoQuang Van LeFrédéric PamoukdjianGuilhem BousquetPublished in: Targeted oncology (2024)
This meta-analysis highlights the toxicity profiles of anti-angiogenic TKI monotherapies, and thus enables high-level recommendations for the choice of anti-angiogenic TKIs on the basis of the patient's age, ethnicity, comorbidities, and comedications, for personalized treatment.